Further validation data with 1367 CRC patients were used, and the result showed that SOX2 expression was associated with worse DFS (HR = 1.30, 95% CI: 1.04–1.62, P=0.02) (Figure 6(b)). The gene discussed is SOX2; the disease is colorectal carcinoma.